33.89
Doximity Inc stock is traded at $33.89, with a volume of 1.02M.
It is up +0.92% in the last 24 hours and up +27.84% over the past month.
Doximity Inc provides an online platform, which enables physicians and other healthcare professionals to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. The Company's customers include pharmaceutical companies and health systems that connect with healthcare professionals through the Company's digital Marketing, Hiring, and Workflow Solutions. Marketing Solutions provide customers with the ability to share tailored content on the network. Hiring Solutions enable customers to identify, connect with, and hire from the network of both active and passive potential medical professional candidates.
See More
Previous Close:
$33.58
Open:
$33.58
24h Volume:
1.02M
Relative Volume:
0.29
Market Cap:
$6.04B
Revenue:
$644.86M
Net Income/Loss:
$196.05M
P/E Ratio:
34.54
EPS:
0.9812
Net Cash Flow:
$317.50M
1W Performance:
+7.59%
1M Performance:
+27.84%
6M Performance:
+39.69%
1Y Performance:
-48.95%
Doximity Inc Stock (DOCS) Company Profile
Name
Doximity Inc
Sector
Industry
Phone
(650) 549-4330
Address
500 THIRD STREET, SUITE 510, SAN FRANCISCO
Compare DOCS vs VEEV, BTSG, TEM, HNGE, HQY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
DOCS
Doximity Inc
|
33.89 | 6.04B | 644.86M | 196.05M | 317.50M | 0.9812 |
|
VEEV
Veeva Systems Inc
|
321.96 | 52.13B | 3.32B | 941.65M | 1.64B | 5.6161 |
|
BTSG
Brightspring Health Services Inc
|
60.37 | 11.95B | 13.65B | 169.86M | 412.12M | 1.0758 |
|
TEM
Tempus Ai Inc
|
62.13 | 11.28B | 1.36B | -302.91M | -219.93M | -1.7182 |
|
HNGE
Hinge Health Inc
|
109.02 | 8.80B | 646.34M | -512.40M | 202.76M | -6.6871 |
|
HQY
Healthequity Inc
|
100.61 | 8.32B | 1.34B | 230.70M | 440.96M | 2.6695 |
Doximity Inc Stock (DOCS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-10-26 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Jun-29-26 | Downgrade | BofA Securities | Buy → Underperform |
| May-15-26 | Downgrade | Barclays | Overweight → Equal Weight |
| May-14-26 | Downgrade | BTIG Research | Buy → Neutral |
| May-14-26 | Downgrade | Jefferies | Buy → Hold |
| May-14-26 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| May-14-26 | Downgrade | Robert W. Baird | Outperform → Neutral |
| May-14-26 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-20-26 | Downgrade | Truist | Buy → Hold |
| Apr-08-26 | Downgrade | Evercore ISI | Outperform → In-line |
| Feb-09-26 | Upgrade | Canaccord Genuity | Hold → Buy |
| Feb-06-26 | Upgrade | JP Morgan | Underweight → Neutral |
| Jan-20-26 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-09-26 | Initiated | RBC Capital Mkts | Outperform |
| Jan-08-26 | Upgrade | Truist | Hold → Buy |
| Dec-15-25 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Dec-09-25 | Initiated | Barclays | Overweight |
| Nov-21-25 | Upgrade | Raymond James | Outperform → Strong Buy |
| Nov-13-25 | Initiated | BMO Capital Markets | Market Perform |
| Oct-27-25 | Upgrade | BofA Securities | Neutral → Buy |
| Oct-10-25 | Downgrade | JP Morgan | Neutral → Underweight |
| Oct-01-25 | Downgrade | Goldman | Neutral → Sell |
| Jul-09-25 | Upgrade | Evercore ISI | In-line → Outperform |
| Jun-02-25 | Upgrade | BTIG Research | Neutral → Buy |
| Feb-07-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Feb-07-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-20-24 | Initiated | Stephens | Equal-Weight |
| Dec-04-24 | Initiated | Mizuho | Neutral |
| Nov-15-24 | Initiated | Goldman | Neutral |
| Nov-14-24 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Nov-13-24 | Downgrade | Canaccord Genuity | Buy → Hold |
| Nov-08-24 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Nov-08-24 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-15-24 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-09-24 | Upgrade | Needham | Hold → Buy |
| Jul-18-24 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Apr-25-24 | Upgrade | JP Morgan | Underweight → Neutral |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Jan-03-24 | Initiated | Barclays | Equal Weight |
| Jan-02-24 | Upgrade | BofA Securities | Underperform → Neutral |
| Aug-09-23 | Downgrade | Guggenheim | Buy → Neutral |
| Aug-09-23 | Downgrade | Needham | Buy → Hold |
| Aug-03-23 | Downgrade | Piper Sandler | Overweight → Neutral |
| May-01-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-06-23 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Oct-31-22 | Initiated | Wells Fargo | Overweight |
| Oct-24-22 | Initiated | Evercore ISI | In-line |
| Oct-13-22 | Initiated | BTIG Research | Neutral |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-07-22 | Initiated | Truist | Hold |
| Aug-05-22 | Downgrade | BofA Securities | Neutral → Underperform |
| Jul-28-22 | Initiated | Berenberg | Buy |
| May-18-22 | Reiterated | BofA Securities | Neutral |
| May-18-22 | Reiterated | Goldman | Buy |
| May-18-22 | Reiterated | Guggenheim | Buy |
| May-18-22 | Reiterated | Jefferies | Buy |
| May-18-22 | Reiterated | Morgan Stanley | Equal-Weight |
| May-18-22 | Reiterated | Needham | Buy |
| Apr-07-22 | Initiated | Guggenheim | Buy |
| Apr-04-22 | Initiated | BofA Securities | Neutral |
| Feb-11-22 | Initiated | Goldman | Buy |
| Dec-14-21 | Downgrade | JP Morgan | Neutral → Underweight |
| Dec-02-21 | Initiated | Jefferies | Buy |
| Nov-17-21 | Initiated | Robert W. Baird | Outperform |
| Nov-10-21 | Reiterated | Canaccord Genuity | Buy |
| Nov-10-21 | Reiterated | Goldman | Neutral |
| Nov-10-21 | Reiterated | Morgan Stanley | Equal-Weight |
| Nov-10-21 | Reiterated | Needham | Buy |
| Nov-10-21 | Reiterated | Piper Sandler | Overweight |
| Aug-26-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-19-21 | Initiated | Canaccord Genuity | Buy |
| Jul-19-21 | Initiated | Goldman | Neutral |
| Jul-19-21 | Initiated | JP Morgan | Overweight |
| Jul-19-21 | Initiated | Morgan Stanley | Equal-Weight |
| Jul-19-21 | Initiated | Piper Sandler | Overweight |
| Jul-19-21 | Initiated | Raymond James | Outperform |
| Jul-19-21 | Initiated | SVB Leerink | Outperform |
| Jul-19-21 | Initiated | William Blair | Outperform |
View All
Doximity Inc Stock (DOCS) Latest News
Bronstein, Gewirtz & Grossman LLC Urges Doximity, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire Inc.
DOCS Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Doximity, Inc. Securities LawsuitContact SueWallSt - Morningstar
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Doximity, Inc. of Class Action Lawsuit and Upcoming DeadlinesDOCS - PR Newswire
DOXIMITY, INC. (DOCS) SHAREHOLDER ALERT Bernstein Liebhard - GlobeNewswire
Doximity, Inc. (DOCS) Stock Forecasts - Yahoo Finance
Doximity (DOCS) Stock Gets Fair Value Bump As Analysts Split On AI And Margins - Yahoo Finance
Bragar Eagel & Squire, P.C. Reminds Doximity, Inc. - GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Doximity, Inc. Investors that a Class Action Lawsuit Has Been Filed Against Doximity and Encourages Investors to Contact the Firm Before November 16th - GlobeNewswire Inc.
DEADLINE ALERT for Baidu, Inc. (BIDU), Doximity, Inc. (DOCS), and Better Home & Finance Holding Company (BETR): The Law Offices of Frank R. Cruz Reminds Investors of Lead Plaintiff Deadlines in Securities Fraud Class Actions - Carroll County Mirror-Democrat
Doximity: Demand For AI-Driven Platforms In Medical Sector Drives Longer-Term Buy (DOCS) - Seeking Alpha
DOCS Shareholder Alert: November 16, 2026 Lead Plaintiff Deadline in Doximity, Inc. Securities Class ActionContact Levi & Korsinsky - Morningstar
DOCS Shareholder Alert: November 16, 2026 Lead Plaintiff Deadline in Doximity, Inc. Securities Class ActionContact Levi & Korsinsky - PR Newswire
Stocks making big moves yesterday: Washington Trust Bancorp, Doximity, Myriad Genetics, Arhaus, and Gartner - Barchart.com
Doximity Inc. Research & Ratings | DOCS1 - Barron's
DOCS1 | Doximity Inc. Stock Overview (Mexico) - Barron's
Doximity Inc (DOCS) Shares Surge 6.0% -- What GF Score of 92 Tel - GuruFocus
Doximity Jumps 6.2% Amid Sector-Wide Rally - AlphaStreet
OpenEvidence, Doximity settle thorny AI legal battle - Healthcare Dive
Doximity, Inc. Stock 12‑Month Price Target Raised to $31.05, Implies 1% Downside - TradingView
Deadline Alert: Doximity, Inc. Investors Have Until November 16, 2026 to Seek Lead Plaintiff Role in Securities Fraud Class Action, Glancy Prongay Wolke & Rotter LLP Reminds - GlobeNewswire Inc.
OpenEvidence, Doximity reach settlement in AI lawsuit - Modern Healthcare
Robbins LLP Urges DOCS Stockholders to Contact the Firm for Information About the Class Action Against Doximity, Inc. - GlobeNewswire
DOCS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announc - The National Law Review
Bronstein, Gewirtz & Grossman LLC Urges Doximity, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire Inc.
Bronstein, Gewirtz & Grossman LLC Urges Doximity, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire
DOCS Deadline Alert: Levi & Korsinsky Reminds Doximity, - GlobeNewswire
Press Release Distribution & Media Outreach Platform for PR Agencies - ACCESS Newswire
Assenagon Asset Management S.A. Makes New $28.86 Million Investment in Doximity, Inc. $DOCS - MarketBeat
Doximity, Inc. (DOCS) Stock Forecasts - Yahoo! Finance Canada
INVESTOR DEADLINE: Doximity, Inc. Investors with Substantial Losses May Seek to Lead Class Action Lawsuit Before November 16, 2026 Deadline, RGRD Law AnnouncesDOCS - GlobeNewswire Inc.
INVESTOR DEADLINE: Doximity, Inc. Investors with - GlobeNewswire
INVESTOR DEADLINE: Doximity, Inc. Investors with Substantial Losses May Seek to Lead Class Action Lawsuit Before November 16, 2026 Deadline, RGRD Law AnnouncesDOCS - lincolnjournal.com
DOCS Investors Have Opportunity to Lead Doximity, Inc. Securities Fraud Lawsuit - The Transylvania Times
Doximity CAO Sitaram sells $80,166 of company stock - Investing.com
ROSEN, LEADING INVESTOR COUNSEL, Encourages Millrose Properties, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionMRP - GlobeNewswire Inc.
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Doximity, Inc. - GlobeNewswire
Why Doximity (DOCS) Dipped More Than Broader Market Today - Zacks Investment Research
Why Doximity (DOCS) Dipped More Than Broader Market Today - Yahoo! Finance Canada
DOCS INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Doximity, Inc. Investors with Substantial Losses May Seek to Lead Class Action Lawsuit Before November 16, 2026 Deadline - PR Newswire
DOCS UPCOMING DEADLINE: Levi & Korsinsky Alerts Doximity, Inc. Stockholders of Securities Class ActionContact the Firm - FinancialContent
DOCS Investors Have Opportunity to Lead Doximity, Inc. Securities Fraud Lawsuit with SBS Law - GlobeNewswire
Fort Washington Investment Advisors Inc. OH Sells 368,718 Shares of Doximity, Inc. $DOCS - MarketBeat
Kaplan Fox Announces a Securities Class Action Filed Against Doximity, Inc. (NYSE: DOCS)Lead Plaintiff Deadline is November 16, 2026 - Barchart.com
Doximity Settles Remaining OpenEvidence AI Prompt-Hack Dispute - Bloomberg Law News
Doximity Settles Remaining OpenEvidence AI Prompt-Hack Dispute - Bloomberg Law News
Doximity to Release Fiscal 2027 Second Quarter Results on November 5, 2026 - Business Wire
Doximity, Inc. (DOCS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
Bronstein, Gewirtz & Grossman LLC Urges Doximity, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire Inc.
Doximity Deepens U.S. News Alliance to Improve Patient Access to Care - Zacks Investment Research
Doximity Deepens U.S. News Alliance to Improve Patient Access to Care - Yahoo Finance
Doximity Inc Stock (DOCS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Doximity Inc Stock (DOCS) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| SIDDHARTH SITARAM | Officer |
Oct 14 '26 |
Proposed Sale |
30.68 |
2,613 |
80,167 |
0 |
| KIRA WAMPLER | Director |
Oct 01 '26 |
Proposed Sale |
28.91 |
2,000 |
57,820 |
0 |
| Wampler Kira Scherer | Director |
Oct 01 '26 |
Sale |
28.91 |
2,000 |
57,820 |
27,923 |
| PHOEBE L YANG WATKIN | Director |
Sep 30 '26 |
Proposed Sale |
26.71 |
1,290 |
34,456 |
0 |
| Yang Watkin Phoebe L. | Director |
Sep 30 '26 |
Sale |
26.71 |
1,290 |
34,456 |
24,744 |
| SIDDHARTH SITARAM | Officer |
Sep 15 '26 |
Proposed Sale |
26.02 |
2,077 |
54,044 |
0 |
| Sitaram Siddharth | Chief Accounting Officer |
Sep 15 '26 |
Sale |
26.02 |
2,077 |
54,044 |
96,045 |
| Wampler Kira Scherer | Director |
Sep 01 '26 |
Sale |
26.33 |
2,000 |
52,660 |
27,923 |
| KIRA WAMPLER | Director |
Sep 01 '26 |
Proposed Sale |
26.33 |
2,000 |
52,660 |
0 |
| Wampler Kira Scherer | Director |
Aug 25 '26 |
Sale |
24.95 |
2,000 |
49,900 |
19,839 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):